Infectious Diseases and Cancer: HPV

Part of the Statistics for Biology and Health book series (SBH)


Many types of cancer are etiologically linked to infections. Historically, it has been a challenge to prove the causal link between an infectious agent and a given type of cancer; different sets of causal criteria have been applied according to the methodological approach used to study the putative association (Franco et al. 2004). Yet, epidemiologic and molecular evidence to date unequivocally demonstrate causal links between viruses, bacteria, and protozoan and metazoan parasites, and many forms of cancer.


Cervical Cancer Cervical Intraepithelial Neoplasia Anal Cancer Penile Cancer Vulvar Cancer 



Cervical cancer research activities in the Division of Cancer Epidemiology at McGill University have been funded by an endowment from the Cancer Research Society and multiple grants from the Canadian Institutes of Health Research (CIHR), National Cancer Institute of Canada (NCIC), and US National Institutes of Health. The authors have also received salary awards from the CIHR (Distinguished Scientist to ELF), Fonds de la recherche en santé du Quebec (Chercheur National to ELF) and chercheur-boursier to HT. Supplemental unconditional financial support to the work of the division has been provided by Merck Frosst.


  1. Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L, Gilks CB (2002) Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol; 84(1):94–101Google Scholar
  2. Aral SO, Holmes KK (1999) Social and behavioural determinants of epidemiology of STDs: industrialized and developing countries. .. In: Holmes KK, Mardh P, Sparling PF, et al. eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill; 39–76Google Scholar
  3. Armstrong LR, Preston EJ, Reichert M, Phillips DL, Nisenbaum R, Todd NW, Jacobs IN, Inglis AF, Manning SC, Reeves WC (2000) Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis; 31(1):107–9Google Scholar
  4. Atalay F, Taskiran C, Taner MZ, Pak I, Or M, Tuncer S (2007) Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol Res; 33(6):823–828Google Scholar
  5. Ateenyi-Agaba C (1995) Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet; 345(8951):695–6Google Scholar
  6. Ateenyi-Agaba C, Weiderpass E, Smet A, Dong W, Dai M, Kahwa B, Wabinga H, Katongole-Mbidde E, Franceschi S, Tommasino M (2004) Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer; 90(9):1777–9Google Scholar
  7. Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 2005 ; 32(suppl 1):S16–24.Google Scholar
  8. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst; 87(11): 796–802.Google Scholar
  9. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol; 55(4):244–65Google Scholar
  10. Brock KE, MacLennan R, Brinton LA, Melnick JL, Adam E, Mock PA, Berry G (1989) Smoking and infectious agents and risk of in situ cervical cancer in Sydney, Australia. Cancer Res; 49(17):4925–8Google Scholar
  11. Chen YC, Chen JH, Richard K, Chen PY, Christiani DC (2004) Lung adenocarcinoma and human papillomavirus infection. Cancer; 15: 1428–36Google Scholar
  12. Chrisofos M, Skolarikos A, Lazaris A, Bogris S, Deliveliotis Ch (2004) HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature. Int J STD AIDS;15(12):836–8Google Scholar
  13. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer; 88:63–73Google Scholar
  14. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE (2005) Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol; 18(12):1606–9Google Scholar
  15. Cubilla AL, Reuter VE, Gregoire L et al. (1998) Basaloid squamous cell carcinoma: A distinctive human papilloma virus-related penile neoplasm—A report of 20 cases. Am J Surg Pathol 22:755–61Google Scholar
  16. Cubilla AL, Velazques EF, Reuter VE et al. (2000) Warty (condylomatous) squamous cell carcinoma of the penis: A report of 11 cases and proposed classification of ‘verruciform’ penile tumors. Am J Surg Pathol 24:505–12Google Scholar
  17. Cullen AP, Reid R, Camption M. Lorincz AT (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol; 65(2):606–12Google Scholar
  18. Cuzick J, Singer A, De Stavola BL, Chomet J (1990) Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer; 26(6):684–90Google Scholar
  19. Dahlstrand H, Dahlgren L, Lindquist D et al. (2004) Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res; 24:1829–35Google Scholar
  20. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 15;101(2):270–80Google Scholar
  21. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol; 84(2):263–70Google Scholar
  22. Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, Ashley RL, Beagrie M, Ryan JA, Corey L (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 15; 317(16):973–7Google Scholar
  23. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO (2004) Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat; 84:131–7Google Scholar
  24. D‘Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med.10; 356(19):1944–56Google Scholar
  25. de Vet HC, Sturmans F (1994) Risk factors for cervical dysplasia: implications for prevention. Public Health;108(4):241–9Google Scholar
  26. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res; 7:R1–11Google Scholar
  27. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology; 324(1):17–27Google Scholar
  28. Dennis LK, Dawson DV (2002) Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology; 13:72–9Google Scholar
  29. Dillner J, von Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl; (205):189–93Google Scholar
  30. El-Mofty SK, Lu DW (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol; 27:1463–70Google Scholar
  31. Eng HL, Lin TM, Chen SY, Wu SM, Chen WJ (2002) Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction.Am J Clin Pathol; 117(3):429–36Google Scholar
  32. Evans AS (1976) Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med; 49(2):175–95Google Scholar
  33. Evans AS, Mueller NE (1990) Viruses and cancer. Causal associations. Ann Epidemiol; 1(1):71–92Google Scholar
  34. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARC Press, LyonGoogle Scholar
  35. Ferreux E, Lont AP, Horenblas S, et al. (2003) Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 201:109–18Google Scholar
  36. Franco EL (1991) Viral etiology of cervical cancer: a critique of the evidence. Rev Infect Dis; 13(6):1195–206Google Scholar
  37. Franco EL, Correa P, Santella RM, Wu X, Goodman SN, Petersen GM (2004) Role and limitations of epidemiology in establishing a causal association. Semin Cancer Biol; 14(6):413–26Google Scholar
  38. Franco EL, Ferenczy A (2002) Part III, site-specific precancerous conditions: Cervix. In: EL Franco, TE Rohan eds. Cancer Precursors: Epidemiology, Detection, and Prevention. New York, NY: Springer- Verlag; 249–86Google Scholar
  39. Franco EL, Rohan TE, Villa LL (1999) Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst; 91: 506–11Google Scholar
  40. Fredricks DN, Relman DA (1998) Infectious agents and the etiology of chronic idiopathic diseases. Curr Clin Top Infect Dis; 18:180–200Google Scholar
  41. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, Goldman S, Svensson C, Adami HO, Melbye M (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med; 337(19):1350–8Google Scholar
  42. Frisch M, Melbye M, Moller H (1993) Trends in incidence of anal cancer in Denmark. BMJ; 306:41922Google Scholar
  43. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA (2005) The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence. Int J Cancer; 117:629–37Google Scholar
  44. Garrote LF, Herrero R, Reyes RM, Vaccarella S, Anta JL, Ferbeye L, Muñoz N, Franceschi S (2001) Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer; 85:46–54Google Scholar
  45. Gichuhi S, Irlam JJ. Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals (2007) Cochrane Database Syst Rev; (2):CD005643Google Scholar
  46. Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol; 31:744–54Google Scholar
  47. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P (2002) Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States–Mexico border. Cancer Epidemiol Biomarkers Prev; 11(9):930–4Google Scholar
  48. Giuliani L, Favalli C, Syrjanen K, Ciotti M (2007) Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res.; 27(4C):2697–704Google Scholar
  49. Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL (2003) Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History study. J Infect Dis; 188:1508–16Google Scholar
  50. Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V (2006) Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol; 108(6):1361–8Google Scholar
  51. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet; 364(9447):1757–65Google Scholar
  52. Harper DM, Franco EL, Wheeler CM et al. (2006) Sustained efficacy up to 4.5 years of a bivalent L1virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet; 367:1247–55Google Scholar
  53. Harris RW, Brinton LA, Cowdell RH, Skegg DC, Smith PG, Vessey MP, Doll R (1980) Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer; 42(3):359–69Google Scholar
  54. Heideman DA, Waterboer T, Pawlita M, Delis-van Diemen P, Nindl I, Leijte JA, Bonfrer JM, Horenblas S, Meijer CJ, Snijders PJ (2007) Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol; 25(29):4550–6Google Scholar
  55. Hellberg D, Valentin J, Eklund T, Nilsson S (1987) Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J (Clin Res Ed).; 295(6609):1306–8Google Scholar
  56. Hemminki K, Dong C, Frisch M (2000) Tonsillar and other upper aerodigestive tract cancer among cervical cancer patient and their husbands. Eur J Cancer Prev; 9: 433–7Google Scholar
  57. Herrero R (1996) Epidemiology of cervical cancer. J Natl Cancer Inst Monogr; 21: 1–6Google Scholar
  58. Holly EA (1996) Cervical intraepithelial neoplasia, cervical cancer, and HPV. Annu Rev Public Health; 17: 69–84Google Scholar
  59. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ (1989) Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst; 81(22):1726–31Google Scholar
  60. Hørding U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE (1994) Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol; 52(2):241–6Google Scholar
  61. Ikenberg H, Runge M, Goppinger A, Pfleiderer A (1990) Human papillomavirus DNA in invasive carcinoma of the vagina. Obstet Gynecol; 76:432–8Google Scholar
  62. International Agency for Research on Cancer (IARC) (1986) Tobacco smoking. Lyon, France: IARC. IARC monographs on the evaluation of carcinogenic risk of chemical to human. Vol. 38Google Scholar
  63. International Agency for Research on Cancer (IARC) (1995) Human papillomaviruses. Lyon, France: IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64Google Scholar
  64. International Agency for Research on Cancer (IARC) (2007) Human Papillomaviruses. Lyon, France: IARC. IARC monographs on the evaluation of carcinogenic risks to humans.,: International Agency for Research on Cancer, vol. 90Google Scholar
  65. Insinga RP, Glass AG, Rush BB (2004) The health care costs of cervical human papillomavirus–related disease. Am J Obstet Gynecol. l; 191(1):114–20Google Scholar
  66. Insinga RP, Glass AG, Rush BB (2004) Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev; 13(3):355–60Google Scholar
  67. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR (2004) Anal cancer incidence and survival: the SEER experience, 1973-2000. Cancer; 101: 281–288Google Scholar
  68. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol; 107(5):1018–22Google Scholar
  69. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD (2002) Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics; 109(1):E5Google Scholar
  70. Kashima HK, Shah F, Lyles A, et al.(1992) A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope; 102:9–13Google Scholar
  71. Kjellberg L, Wang Z, Wiklund F, Edlund K, Angstrom T, Lenner P, Sjoberg I, Hallmans G, Wallin KL, Sapp M, Schiller J, Wadell G, Mahlck CG, Dillner J (1999) Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol; 80(Pt 2):391–8Google Scholar
  72. Klussmann JP, Gultekin E, Weissenborn SJ, et al. (2003a) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. AmJ Pathol; 162:747–53Google Scholar
  73. Klussmann JP, Weissenborn SJ, Wieland U, et al. (2003b) Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol (Berl);192:129–32Google Scholar
  74. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG (2001) Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer ; 92:2875–84.Google Scholar
  75. Konidaris S, Kouskouni EE, Panoskaltsis T, Kreatsas G, Patsouris ES, Sarivalassis A, Nonni A, Lazaris AC (2007) Human papillomavirus infection in malignant and benign gynaecological conditions: a study in Greek women. Health Care Women Int; 28(2):182–91Google Scholar
  76. Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med; 102(5A):3–8Google Scholar
  77. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML (2004) Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis; 189: 686–98Google Scholar
  78. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck SCCs worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev; 14:467–75Google Scholar
  79. Lee YM, Leu SY, Chiang H, Chiang H, Fung CP, Liu WT (2001) Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect; 34: 87–91Google Scholar
  80. Maciag PC, Schlecht NF, Souza PS, Rohan TE, Franco EL, Villa LL (2002) Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. J Infect Dis; 186: 164–72Google Scholar
  81. Macfarlane GJ, Boyle P, Scully C (1992) Oral cancer in Scotland: changing incidence and mortality. BMJ; 305:1121–3Google Scholar
  82. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst; 89:1516–23Google Scholar
  83. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, Corey L, Daling JR (1992) Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer inmen. AmJ Epidemiol; 135:1093–102Google Scholar
  84. Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, Daling JR (1993) History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst; 85(1):19–24Google Scholar
  85. Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR (1993) Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. Urology; 42(2):159–70Google Scholar
  86. Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis; 29: 725–35Google Scholar
  87. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL (2007) Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med; 357(16):1579–88Google Scholar
  88. McDonnell JM, McDonnell PJ, Sun YY (1992) Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci;33(1):184–9Google Scholar
  89. McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD (2002) Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol; 86(2):168–73Google Scholar
  90. Melbye M, Rabkin C, Frisch M, Biggar RJ (1994) Changing patterns of anal cancer incidence in the United States, 19401989. Am J Epidemiol; 139:77280Google Scholar
  91. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med; 344:1125–31Google Scholar
  92. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J (2001) Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA; 285:2995–3002Google Scholar
  93. Moubayed P, Mwakyoma H, Schneider DT (2004) High frequency of human papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania. Am J Clin Pathol; 122(6):938–43Google Scholar
  94. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer; 111(2):278–85Google Scholar
  95. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med; 348(6):518–27Google Scholar
  96. Muñoz N, Castellsagué X, de González AB, Gissmann L (2006)  Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006 Aug 21; 24S3:S1–10
  97. Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y (1997) Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction. Br J Ophthalmol; 81(4):308–13Google Scholar
  98. Newton R (1996) A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br J Cancer; 74(10):1511–3Google Scholar
  99. Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, Orlow I, Gerald W, Cordon-Cardo C (2000) Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res; 6(10):4010–6Google Scholar
  100. Palazzi MA, Erwenne CM, Villa LL (2000) Detection of human papillomavirus in epithelial lesions of the conjunctiva. Sao Paulo Med J; 118(5):125–30Google Scholar
  101. Palazzi MA, Yunes JA, Cardinalli IA, Stangenhaus GP, Brandalise SR, Ferreira SA, Sobrinho JS, Villa LL (2003) Detection of oncogenic human papillomavirus in sporadic retinoblastoma. Acta Ophthalmol Scand; 81(4):396–8Google Scholar
  102. Palefsky JM (2000b) Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol.; 27(4):471–9Google Scholar
  103. Palefsky JM (2000a) Human papilloma virus related tumors. AIDS; 14(Suppl 3):S18995Google Scholar
  104. Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS (1991) Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res; 51(3):1014–9Google Scholar
  105. Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L (1992) Risk factors for cervical intraepithelial neoplasia. Cancer; 69(9):2276–82Google Scholar
  106. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer; 118(12):3030–44.Google Scholar
  107. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin; 55(2):74–108Google Scholar
  108. Parkin DM, Whelan SL, Ferlay J, et al. (2002) Cancer Incidence in Five Continents. Lyon, France, IARC Scientific Publication 155Google Scholar
  109. Parkin DM, Whelan S, Ferlay J, Raymond LE, Young J (1997) Cancer incidence in five continents, Vol. VII. Lyon: International Agency for Research on Cancer, IARC Scientific Publications No. 143Google Scholar
  110. Pirami L, Giache V, Becciolini A (1997) Analysis of HPV 16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix 1997. J Clin Pathol; 50(7):600–4Google Scholar
  111. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer; 83:18–29Google Scholar
  112. Pérez LO, Abba MC, Laguens RM, Golijow CD (2005) Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis; 7(5):492–5Google Scholar
  113. Pfister H (2003)  Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr; 31:52–6Google Scholar
  114. Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res; 86(2):104–14Google Scholar
  115. Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med; 342:792– 800Google Scholar
  116. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev;12:485–90Google Scholar
  117. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK eds. (2000) SEER Cancer Statistics Review, 1973–1997, National Cancer Institute. Bethesda, MDGoogle Scholar
  118. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. eds.(2006) SEER Cancer Statistics Review, 1975-2003. Bethesda (MD): National Cancer Institute. Available at:
  119. Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE (2000) A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev; 9:469–76Google Scholar
  120. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol; 159(4):1211–8Google Scholar
  121. Schaffer A, Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak MN, Franco EL (2007) Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev; 16(4):716–22Google Scholar
  122. Schantz SP, Yu GP (2002) Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer.Arch Otolaryngol Head Neck Surg; 128(3):268–74Google Scholar
  123. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, et al. (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst; 85(12): 958–64Google Scholar
  124. Schiffman MH, Brinton LA (1995) The epidemiology of cervical carcinogenesis. Cancer; 76 (10 Suppl): 1888–901Google Scholar
  125. Schiffman M, Castle PE (2003b) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med; 127(8):930–4Google Scholar
  126. Schiffman M, Kjaer SK (2003)  Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr; (31):14–9
  127. Schlecht NF, Trevisan A, Duarte-Franco E, et al. (2003) Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer; 103:519–24Google Scholar
  128. Scott IU, Karp CL, Nuovo GJ (2002) Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology; 109(3):542–7Google Scholar
  129. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A (2003) Survey of HPV in Ontario Women Group. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ;168:421–5Google Scholar
  130. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ (2002) Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer; 2(1):37Google Scholar
  131. Shiboski CH, Shiboski SC, Silverman SJ (2000) Trends in oral cancer rates in the United States, 1973–1996. Community Dent Oral Epidemiol; 28:249–56Google Scholar
  132. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL (2007) High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer; 120(8):1763–8Google Scholar
  133. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV (2003) Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol; 101:645–52Google Scholar
  134. Sjö NC, von Buchwald C, Cassonnet P, Norrild B, Prause JU, Vinding T, Heegaard S (2007) Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol; 91(8):1014–5Google Scholar
  135. Spence AR, Franco EL, Ferenczy A (2005) The role of human papillomavirus in cancer. Am J Cancer; 4(1):49–64Google Scholar
  136. Stone KM, Timyan J, Thomas EL (1999) Barrier methods for the prevention of sexually transmitted diseases. In: Holmes KK, Mardh P, Sparling PF, et al. eds.. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw- Hill:1307–21Google Scholar
  137. Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ, Zenilman JM, Jacobson LP, De Marzo AM, Willett WC, Platz EA (2007) Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev; 16(8):1573–80Google Scholar
  138. Syrjanen S (2005) Human papillomavirus (HPV) in head and neck cancer. J Clin Virol; 32 Suppl 1:S59–66Google Scholar
  139. Tabrizi SN, McCurrach FE, Drewe RH, Borg AJ, Garland SM, Taylor HR (1997) Human papillomavirus in corneal and conjunctival carcinoma. Aust N Z J Ophthalmol; 25(3):211–5Google Scholar
  140. Tran N, Rose BR, O‘Brien CJ (2007) Role of human papillomavirus in the etiology of head and neck cancer. Head Neck; 29(1):64–70Google Scholar
  141. Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine; 24 Suppl 1:S1–15Google Scholar
  142. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M (2004) Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res; 23:561–6Google Scholar
  143. Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, Brown DR, Ferenczy A, Harper DM, Koutsky LA, Kurman RJ, Lehtinen M, Malm C, Olsson SE, Ronnett BM, Skjeldestad FE, Steinwall M, Stoler MH, Wheeler CM, Taddeo FJ, Yu J, Lupinacci L, Railkar R, Marchese R, Esser MT, Bryan J, Jansen KU, Sings HL, Tamms GM, Saah AJ, Barr E (2006) Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine; 24:5571–83Google Scholar
  144. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol; 189: 12–9Google Scholar
  145. Walboomers JM, Meijer CJ (1997) Do HPV-negative cervical carcinomas exist? J Pathol; 181: 253–4Google Scholar
  146. Wang SS, Hildesheim A (2003)  Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr; (31):35–40
  147. Welton ML, Sharkey FE, Kahlenberg MS (2004) The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am; 13:263–75Google Scholar
  148. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol; 157(3):218–26Google Scholar
  149. Winer RL, Hughes JP, Feng Q et al. (2006) Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med; 354:2645–54Google Scholar
  150. Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT, Baithun S (2005) Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol; 58(2):207–10Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and BiostatisticsMcGill UniversityMontrealCanada

Personalised recommendations